By Hugo Kubinyi, Gerd Folkers, Yvonne C. Martin
Volumes 2 and three of the 3D QSAR in Drug layout sequence target to check the growth being made in CoMFA and different 3D QSAR methods because the booklet of the hugely winning first quantity approximately 4 years in the past. quantity 2 (Ligand-Protein Interactions and Molecular Similarity) divides into 3 sections facing Ligand-Protein Interactions, Quantum Chemical types and Molecular Dynamics Simulations, and Pharmacophore Modelling and Molecular Similarity, respectively. quantity three (Recent Advances) can be divided into 3 sections, particularly 3D QSAR method: CoMFA and similar techniques, Receptor versions and different 3D QSAR ways, and 3D QSAR functions. greater than seventy amazing scientists have contributed approximately 40 reports in their paintings and comparable study to those volumes that are of exceptional caliber and timeliness. those works current an updated insurance of the most recent advancements in all fields of 3D QSAR.
Read or Download 3D QSAR in Drug Design: Volume 3: Recent Advances (Three-Dimensional Quantitative Structure Activity Relationships, Volume 3) PDF
Similar pharmacology books
This booklet presents info at the use of psychotropic medications in scientific perform. The e-book covers every thing from the elemental technology of pharmacology to systematic assessment of all at present to be had information at the use of psychotropic medicines. due to its insurance of uncomplicated technology and the background of psychotropic medicines, this booklet may be particular for tutorial use.
The metabolic syndrome is a standard syndrome affecting approximately 20 % of the grownup inhabitants in Europe, and possibly the superiority is of an analogous value in different industrialised international locations world wide. it really is customarily brought on by western way of life leading to stomach weight problems, but in addition a genetic predisposition performs a task.
- Pharmacology of the Coronary Circulation. Volume 10
- Cyclophosphamide - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Ethnicity and Psychopharmacology
- Silver in healthcare : its antimicrobial efficacy and safety in use
- Biogenic Amines: Pharmacological, Neurochemical and Molecular Aspects in the CNS
Additional info for 3D QSAR in Drug Design: Volume 3: Recent Advances (Three-Dimensional Quantitative Structure Activity Relationships, Volume 3)
Comparative molecular field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. , 110 (1988) 5959–5967. 76. H. substituted imidazoles, and 1-melhyl-2-substituted-imidazoles from 3D structures using a comparative molecular field analysis (CoMFA) approach, J. Med. , 34 (1991) 2056–2060. 77. , Comparison of classical and 3D QSAR, In K u b i n y i , H. ) 3D QSAR in drug design: Theory methods and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 619–642.
Med. , 36 (1993) 2390–2403. L. , Three-dimensional quantitative structure–activity relationship of human immunodeficiency virus (I) protease inhibitors: 2. Predictive power using limited exploration of alternative binding modes, J. Med. , 37 (1994) 2206–2215. , Fittkau, S. , CoMFA investigation on two series of artificial peplide inhibitors of the serine protease thermitase. Int. J. , 46 (1995) 73–78. , Ettmayer, P. , 3D-quantitative structure-activity relationships of human immunodeficiency virus type-1 protease inhibitors: Comparative molecular field analysis of 2-heterosubstilutt'd statine derivatives — implications for the design of novel inhibitors, J.
54. , Lico, I. , unpublished observations. 55. H. , Evaluation of electrostatic and steric descriptors of 3D-QSAR: The H+ and CH3 probes using comparative molecular field analysis (CoMFA) and the modified partial least squares method, In Silipo, C. and Vittoria, A. ) QSAR: Rational approaches to the design of bioactive compounds, Elsevier Science Publishers, Amsterdam, The Netherlands, 1991, pp. 151–54. 56. , Abraham, M. , Solubility pro- perties in biological media: 9. , J. Pharm. , 76 (1987) 14–17.